tirzepatide obesity trial non-diabetic (Zepbound) for the Treatment of surmount-1 trial tirzepatide weight loss
Description
Diarrhea : Some people may experience loose stools or more frequent trips to the bathroom
boxed warning , the most serious type of warning from the Food and Drug Administration (FDA)
Severe stomachacheCall your doctor if you experience severe stomach problems
Compounded products vary by pharmacy and may have inconsistent potency, contamination risk, or untested formulations
These numbers represent 72-week averages
